Table of Content

1. Report Introduction

2. Acute Pancreatitis Market Overview at a Glance
2.1. Global Market Size of Acute Pancreatitis in 2017
2.2. Global Market Size of Acute Pancreatitis in 2028

3. Disease Background and Overview: Acute Pancreatitis
3.1. Introduction
3.2. Causes
3.3. Pathophysiology
3.4. Symptoms
3.5. Risk Factor
3.6. Diagnosis

4. Epidemiology and Patient Population
4.1. Assumptions and Caveats
4.2. Acute Pancreatitis Geography Wise Incident Cases
4.2.1. 7MM Diagnosed Incidence of Acute Pancreatitis (2017-2028)
4.2.2. 7MM Diagnosed Incidence of AP by Etiology (2017-2028)
4.2.3. 7MM Diagnosed Incidence of AP by Severity (2017-2028)
4.2.4. 7MM Diagnosed Incidence of AP by Gender (2017-2028)
4.2.5. 7MM Diagnosed Incidence of Recurrent AP Cases (2017-2028)
4.3. United States
4.3.1. Diagnosed Incidence of Acute Pancreatitis in United States (2017-2028)
4.3.2. Diagnosed Incidence of AP by Etiology in United States (2017-2028)
4.3.3. Diagnosed Incidence of AP by Severity in United States (2017-2028)
4.3.4. Diagnosed Incidence of AP by Gender in United States (2017-2028)
4.3.5. Diagnosed Incidence of Recurrent AP Cases in United States (2017-2028)
4.4. EU-5
4.4.1. Assumptions and Rationale
4.4.2. Germany
4.4.2.1. Diagnosed Incidence of Acute Pancreatitis in Germany (2017-2028)
4.4.2.2. Diagnosed Incidence of AP by Etiology in Germany (2017-2028)
4.4.2.3. Diagnosed Incidence of AP by Severity in Germany (2017-2028)
4.4.2.4. Diagnosed Incidence of AP by Gender in Germany (2017-2028)
4.4.2.5. Diagnosed Incidence of Recurrent AP Cases in Germany (2017-2028)
4.4.3. Italy
4.4.3.1. Diagnosed Incidence of Acute Pancreatitis in Italy (2017-2028)
4.4.3.2. Diagnosed Incidence of AP by Etiology in Italy (2017-2028)
4.4.3.3. Diagnosed Incidence of AP by Severity in Italy (2017-2028)
4.4.3.4. Diagnosed Incidence of AP by Gender in Italy (2017-2028)
4.4.3.5. Diagnosed Incidence of Recurrent AP Cases in Italy (2017-2028)
4.4.4. Spain
4.4.4.1. Diagnosed Incidence of Acute Pancreatitis in Spain (2017-2028)
4.4.4.2. Diagnosed Incidence of AP by Etiology in Spain (2017-2028)
4.4.4.3. Diagnosed Incidence of AP by Severity in Spain (2017-2028)
4.4.4.4. Diagnosed Incidence of AP by Gender in Spain (2017-2028)
4.4.4.5. Diagnosed Incidence of Recurrent AP Cases in Spain (2017-2028)
4.4.5. France
4.4.5.1. Diagnosed Incidence of Acute Pancreatitis in France (2017-2028)
4.4.5.2. Diagnosed Incidence of AP by Etiology in France (2017-2028)
4.4.5.3. Diagnosed Incidence of AP by Severity in France (2017-2028)
4.4.5.4. Diagnosed Incidence of AP by Gender in France (2017-2028)
4.4.5.5. Diagnosed Incidence of Recurrent AP Cases in France (2017-2028)
4.4.6. United Kingdom
4.4.6.1. Diagnosed Incidence of Acute Pancreatitis in UK (2017-2028)
4.4.6.2. Diagnosed Incidence of AP by Etiology in UK (2017-2028)
4.4.6.3. Diagnosed Incidence of AP by Severity in UK (2017-2028)
4.4.6.4. Diagnosed Incidence of AP by Gender in UK (2017-2028)
4.4.6.5. Diagnosed Incidence of Recurrent AP Cases in UK (2017-2028)
4.5. Japan
4.5.1. Diagnosed Incidence of Acute Pancreatitis in Japan (2017-2028)
4.5.2. Diagnosed Incidence of AP by Etiology in Japan (2017-2028)
4.5.3. Diagnosed Incidence of AP by Severity in Japan (2017-2028)
4.5.4. Diagnosed Incidence of AP by Gender in Japan (2017-2028)
4.5.5. Diagnosed Incidence of Recurrent AP Cases in Japan (2017-2028)

5. Treatment Algorithm
5.1. United States
5.2. Europe
5.3. Japan

6. Unmet Need

7. Key Emerging Therapies
7.1. Key Cross Competition
7.2. CM4620: CalciMedica
7.2.1. Regulatory Milestones
7.2.2. Clinical Development
7.2.3. Product Profile
7.2.4. Clinical Pipeline Activity
7.2.4.1. Ongoing Trials Information
7.2.4.2. Clinical Trial by Phase

8. Acute Pancreatitis Market Size
8.1. Key Findings
8.2. Total 7MM Acute Pancreatitis Market Analysis
8.2.1. Overview of Total Acute Pancreatitis Market (2017-2028)

9. 7MM Acute Pancreatitis: Country-Wise Market Analysis
9.1. United States Market Size
9.1.1. Total Market Size
9.1.2. Market Size by Therapies
9.2. Germany Market Size
9.2.1. Total Market Size
9.2.2. Market Size by Therapies
9.3. France Market Size
9.3.1. Total Market Size
9.3.2. Market Size by Therapies
9.4. United Kingdom Market Size
9.4.1. Total Market Size
9.4.2. Market Size by Therapies
9.5. Spain Market Size
9.5.1. Total Market Size
9.5.2. Market Size by Therapies
9.6. Italy Market Size
9.6.1. Total Market Size
9.6.2. Market Size by Therapies
9.7. Japan Market Size
9.7.1. Total Market Size
9.7.2. Market Size by Therapies

10. Market Drivers

11. Market Barriers

12. Report Methodology
12.1. Sources Used

13. DelveInsight Capabilities

14. Disclaimer

15. About DelveInsight



List of Figures


Figure 1 Diagnosed Incidence of Acute Pancreatitis in 7MM (2017-2028)
Figure 2 Diagnosed Incidence of AP by Etiology in 7MM (2017-2028)
Figure 3 Diagnosed Incidence of AP by Severity in 7MM (2017-2028)
Figure 4 Diagnosed Incidence of AP by Gender in 7MM (2017-2028)
Figure 5 Diagnosed Incidence of Recurrent AP Cases in 7MM (2017-2028)
Figure 6 Diagnosed Incidence of Acute Pancreatitis in United States (2017-2028)
Figure 7 Diagnosed Incidence of AP by Etiology in United States (2017-2028)
Figure 8 Diagnosed Incidence of AP by Severity in United States (2017-2028)
Figure 9 Diagnosed Incidence of AP by Gender in United States (2017-2028)
Figure 10 Diagnosed Incidence of Recurrent AP Cases in United States (2017-2028)
Figure 11 Diagnosed Incidence of Acute Pancreatitis in Germany (2017-2028)
Figure 12 Diagnosed Incidence of AP by Etiology in Germany (2017-2028)
Figure 13 Diagnosed Incidence of AP by Severity in Germany (2017-2028)
Figure 14 Diagnosed Incidence of AP by Gender in Germany (2017-2028)
Figure 15 Diagnosed Incidence of Recurrent AP Cases in Germany (2017-2028)
Figure 16 Diagnosed Incidence of Acute Pancreatitis in France (2017-2028)
Figure 17 Diagnosed Incidence of AP by Etiology in France (2017-2028)
Figure 18 Diagnosed Incidence of AP by Severity in France (2017-2028)
Figure 19 Diagnosed Incidence of AP by Gender in France (2017-2028)
Figure 20 Diagnosed Incidence of Recurrent AP Cases in France (2017-2028)
Figure 21 Diagnosed Incidence of Acute Pancreatitis in Italy (2017-2028)
Figure 22 Diagnosed Incidence of AP by Etiology in Italy (2017-2028)
Figure 23 Diagnosed Incidence of AP by Severity in Italy (2017-2028)
Figure 24 Diagnosed Incidence of AP by Gender in Italy (2017-2028)
Figure 25 Diagnosed Incidence of Recurrent AP Cases in Italy (2017-2028)
Figure 26 Diagnosed Incidence of Acute Pancreatitis in Spain (2017-2028)
Figure 27 Diagnosed Incidence of AP by Etiology in Spain (2017-2028)
Figure 28 Diagnosed Incidence of AP by Severity in Spain (2017-2028)
Figure 29 Diagnosed Incidence of AP by Gender in Spain (2017-2028)
Figure 30 Diagnosed Incidence of Recurrent AP Cases in Spain (2017-2028)
Figure 31 Diagnosed Incidence of Acute Pancreatitis in United Kingdom (2017-2028)
Figure 32 Diagnosed Incidence of AP by Etiology in United Kingdom (2017-2028)
Figure 33 Diagnosed Incidence of AP by Severity in United Kingdom (2017-2028)
Figure 34 Diagnosed Incidence of AP by Gender in United Kingdom (2017-2028)
Figure 35 Diagnosed Incidence of Recurrent AP Cases in United Kingdom (2017-2028)
Figure 36 Diagnosed Incidence of Acute Pancreatitis in Japan (2017-2028)
Figure 37 Diagnosed Incidence of AP by Etiology in Japan (2017-2028)
Figure 38 Diagnosed Incidence of AP by Severity in Japan (2017-2028)
Figure 39 Diagnosed Incidence of AP by Gender in Japan (2017-2028)
Figure 40 Diagnosed Incidence of Recurrent AP Cases
Figure 41 CM4620, Clinical Trials by Recruitment status, 2019
Figure 42 CM4620, Clinical Trials by Zone, 2019
Figure 43 Total 7 Major Market Size of Acute Pancreatitis in USD, Million (2017-2028)
Figure 44 Region wise Market Size of Acute Pancreatitis in USD, Million (2017-2028)
Figure 45 United States Market Size of Acute Pancreatitis by Therapies in USD, Million (2017-2028)
Figure 46 United States Market Size of Acute Pancreatitis in USD, Million (2017-2028)
Figure 47 Germany Market Size of Acute Pancreatitis by Therapies in USD, Million (2017-2028)
Figure 48 Germany Market Size of Acute Pancreatitis in USD, Million (2017-2028)
Figure 49 France Market Size of Acute Pancreatitis by Therapies in USD, Million (2017-2028)
Figure 50 France Market Size of Acute Pancreatitis in USD, Million (2017-2028)
Figure 51 United Kingdom Market Size of Acute Pancreatitis in USD, Million (2017-2028)
Figure 52 United Kingdom Market Size of Acute Pancreatitis by Therapies in USD, Million (2017-2028)
Figure 53 Spain Market Size of Acute Pancreatitis in USD, Million (2017-2028)
Figure 54 Spain Market Size of Acute Pancreatitis by Therapies in USD, Million (2017-2028)
Figure 55 Italy Market Size of Acute Pancreatitis in USD, Million (2017-2028)
Figure 56 Italy Market Size of Acute Pancreatitis by Therapies in USD, Million (2017-2028)
Figure 57 Japan Market Size of Acute Pancreatitis in USD, Million (2017-2028)
Figure 58 Japan Market Size of Acute Pancreatitis by Therapies in USD, Million (2017-2028)

 

List of Tables


Table 1 Diagnosed Incidence of Acute Pancreatitis in 7MM (2017-2028)
Table 2 Diagnosed Incidence of AP by Etiology in 7MM (2017-2028)
Table 3 Diagnosed Incidence of AP by Severity in 7MM (2017-2028)
Table 4 Diagnosed Incidence of AP by Gender in 7MM (2017-2028)
Table 5 Diagnosed Incidence of Recurrent AP Cases in 7MM (2017-2028)
Table 6 Diagnosed Incidence of Acute Pancreatitis in United States (2017-2028)
Table 7 Diagnosed Incidence of AP by Etiology in United States (2017-2028)
Table 8 Diagnosed Incidence of AP by Severity in United States (2017-2028)
Table 9 Diagnosed Incidence of AP by Gender in United States (2017-2028)
Table 10 Diagnosed Incidence of Recurrent AP Cases in United States (2017-2028)
Table 11 Diagnosed Incidence of Acute Pancreatitis in Germany (2017-2028)
Table 12 Diagnosed Incidence of AP by Etiology in Germany (2017-2028)
Table 13 Diagnosed Incidence of AP by Severity in Germany (2017-2028)
Table 14 Diagnosed Incidence of AP by Gender in Germany (2017-2028)
Table 15 Diagnosed Incidence of Recurrent AP Cases in Germany (2017-2028)
Table 16 Diagnosed Incidence of Acute Pancreatitis in France (2017-2028)
Table 17 Diagnosed Incidence of AP by Etiology in France (2017-2028)
Table 18 Diagnosed Incidence of AP by Severity in France (2017-2028)
Table 19 Diagnosed Incidence of AP by Gender in France (2017-2028)
Table 20 Diagnosed Incidence of Recurrent AP Cases in France (2017-2028)
Table 21 Diagnosed Incidence of Acute Pancreatitis in Italy (2017-2028)
Table 22 Diagnosed Incidence of AP by Etiology in Italy (2017-2028)
Table 23 Diagnosed Incidence of AP by Severity in Italy (2017-2028)
Table 24 Diagnosed Incidence of AP by Gender in Italy (2017-2028)
Table 25 Diagnosed Incidence of Recurrent AP Cases in Italy (2017-2028)
Table 26 Diagnosed Incidence of Acute Pancreatitis in Spain (2017-2028)
Table 27 Diagnosed Incidence of AP by Etiology in Spain (2017-2028)
Table 28 Diagnosed Incidence of AP by Severity in Spain (2017-2028)
Table 29 Diagnosed Incidence of AP by Gender in Spain (2017-2028)
Table 30 Diagnosed Incidence of Recurrent AP Cases in Spain (2017-2028)
Table 31 Diagnosed Incidence of Acute Pancreatitis in United Kingdom (2017-2028)
Table 32 Diagnosed Incidence of AP by Etiology in United Kingdom (2017-2028)
Table 33 Diagnosed Incidence of AP by Severity in United Kingdom (2017-2028)
Table 34 Diagnosed Incidence of AP by Gender in United Kingdom (2017-2028)
Table 35 Diagnosed Incidence of Recurrent AP Cases in United Kingdom (2017-2028)
Table 36 Diagnosed Incidence of Acute Pancreatitis in Japan (2017-2028)
Table 37 Diagnosed Incidence of AP by Etiology in Japan (2017-2028)
Table 38 Diagnosed Incidence of AP by Severity in Japan (2017-2028)
Table 39 Diagnosed Incidence of AP by Gender in Japan (2017-2028)
Table 40 Diagnosed Incidence of Recurrent AP Cases in Japan (2017-2028)
Table 41 CM4620, Clinical Trials by Recruitment status, 2019
Table 42 CM4620, Clinical Trials by Zone, 2019
Table 43 Total 7 Major Market Size of Acute Pancreatitis in USD, Million (2017-2028)
Table 44 Region wise Market Size of Acute Pancreatitis in USD, Million (2017-2028)
Table 45 United States Market Size of Acute Pancreatitis by Therapies in USD, Million (2017-2028)
Table 46 United States Market Size of Acute Pancreatitis in USD, Million (2017-2028)
Table 47 Germany Market Size of Acute Pancreatitis by Therapies in USD, Million (2017-2028)
Table 48 Germany Market Size of Acute Pancreatitis in USD, Million (2017-2028)
Table 49 France Market Size of Acute Pancreatitis by Therapies in USD, Million (2017-2028)
Table 50 France Market Size of Acute Pancreatitis in USD, Million (2017-2028)
Table 51 United Kingdom Market Size of Acute Pancreatitis in USD, Million (2017-2028)
Table 52 United Kingdom Market Size of Acute Pancreatitis by Therapies in USD, Million (2017-2028)
Table 53 Spain Market Size of Acute Pancreatitis in USD, Million (2017-2028)
Table 54 Spain Market Size of Acute Pancreatitis by Therapies in USD, Million (2017-2028)
Table 55 Italy Market Size of Acute Pancreatitis in USD, Million (2017-2028)
Table 56 Italy Market Size of Acute Pancreatitis by Therapies in USD, Million (2017-2028)
Table 57 Japan Market Size of Acute Pancreatitis in USD, Million (2017-2028)
Table 58 Japan Market Size of Acute Pancreatitis by Therapies in USD, Million (2017-2028)